Pfizer Ltd. News and Updates

Keep track of all breaking news on Pfizer Ltd. from all sources in a single place.

23 May 2025

5417.60

4.53%

FDA may change Covid-19 booster rules from 2025: What it means for you

Business Standard

The US Food and Drug Administration may limit Covid-19 boosters shots to high-risk groups from 2025; Pfizer reviewing proposal as agency seeks new trials, clearer risk labels for younger males

Pfizer Ltd. is trading above all available SMAs

Pfizer Ltd.

20 May 2025

5417.60

4.53%

Pfizer Q4 net profit jumps 85% to 331 crore; revenue rises 8.3%

Business Standard

Pfizer's Q4 profit surged to 331 crore, aided by a 172 crore gain from land sale; board declares 165 dividend per share, including special payouts for FY25

Pfizer Ltd. has gained 27.51% in the last 1 Month

Pfizer share climbs 11% post healthy Q4; announces Rs 165 dividend for FY25

Business Standard | 20 May 2025

Pfizer Ltd.

12 May 2025

5417.60

4.53%

Trump Vows US Drug Price Cuts Of Up To 80% In Pharma Industry Blow

NDTV Profit

Shares in US drugmakers dropped before the official open on trading in New York, with Eli Lilly & Co., Pfizer Inc., Bristol-Myers Squibb Co. and Merck & Co. Inc. all down.

Pfizer Ltd. is trading above all available SMAs

Pfizer Ltd.

29 Apr 2025

5417.60

4.53%

Pfizer beats Q1 profit estimates on cost cut, strong sale of heart drug

Business Standard

It reported total revenue of $13.70 billion for the first quarter, compared with analysts' expectations of $13.91 billion, according to LSEG data

Pfizer Ltd. has gained 27.51% in the last 1 Month

Pfizer Ltd.

14 Apr 2025

5417.60

4.53%

Pfizer ends development of promising obesity pill after safety concerns

Business Standard

According to the company's latest statement, one patient experienced a potential liver injury that may have been caused by the drug

Pfizer Ltd. has gained 31.33% in the last 3 Months

Pfizer Ltd.

09 Apr 2025

5417.60

4.53%

Pfizer, Amgen, Johnson & Johnson, others drop at US market open amid Trump's US pharma tariff fears

livemint

US Markets Today: Pfizer, Amgen, and Johnson & Johnson were among other pharma stocks that dropped at the US market open on April 9 amid investor fears over Donald Trump's upcoming US pharma tariffs.

Pfizer Ltd. has gained 27.51% in the last 1 Month

Pfizer Ltd.

08 Apr 2025

5417.60

4.53%

Pfizer's Dr Seema Pai appointed as head of Indian Society for Clinical Research

Business Line

Alongside her, Anirban Roychowdhury has been named Honorary General Secretary, and Amita Bhave will serve as Treasurer

Pfizer Ltd. has gained 31.33% in the last 3 Months

Pfizer Ltd.

27 Mar 2025, 05:19PM

5417.60

4.53%

US prosecutors investigate tip about timing of Pfizer's Covid vaccine

Business Standard

The report said on Wednesday GSK's former head of vaccine development, Philip Dormitzer, had told his colleagues about the delay by Pfizer, where he worked before joining the British company

Pfizer Ltd. has gained 21.25% in the last 1 Week

Pfizer Ltd.

11 Mar 2025

5417.60

4.53%

Pfizer's breast cancer drug Vepdegestrant posts mixed results in key trial

Business Standard

The drug, vepdegestrant, failed to meaningfully delay cancer progression for all patients enrolled in the study but met its goals for a subset who have a specific genetic mutation

Pfizer Ltd. has gained 21.25% in the last 1 Week

Pfizer Ltd.

03 Mar 2025

5417.60

4.53%

Pfizer may move outside manufacturing plants to US: CEO amid tariff threats

Business Standard

The US president has imposed a 10 per cent tariff across all Chinese imports into the US and proposed a 25 per cent levy on most goods from Mexico and Canada

Pfizer Ltd. has gained 27.51% in the last 1 Month

Is Pfizer Ltd. worth buying?

203 Votes:

Buy 74.88%

Sell 15.27%

Hold 9.85%

46.38% Gain from 52W Low

Pfizer Ltd. News and Updates

Keep track of all breaking news on Pfizer Ltd. from all sources in a single place.